Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Watson Pharmaceuticals to Host First Quarter 2004 Earnings Conference Call and Webcast

CORONA, Calif., April 22 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it will release its first quarter 2004 financial results on Wednesday, April 28, 2004 after the close of the trading day. The Company will also host a conference call and webcast at 2:00 p.m. Pacific Daylight Time on that day to discuss the results and provide an outlook for the second quarter and full year 2004. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Daylight Time on May 5, 2004. The replay may be accessed by dialing (800) 642-1687 and entering passcode 6656431. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same passcode. To access the webcast, go to Watson's Investor Relations Web site at http://ir.watsonpharm.com. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )

SOURCE Watson Pharmaceuticals, Inc.

/CONTACT: Investors, Patty Eisenhaur, +1-909-493-5611, or Media, Chris
Eso, +1-909-493-4013, both of Watson Pharmaceuticals, Inc./
/Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com/
/Web site: http://ir.watsonpharm.com /
/Web site: http://www.watsonpharm.com /

<< Back
ELECTRONIC ENROLLMENT